All Stories
- ArticleTHERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES
- ArticleIS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?
- ArticleCAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
- ArticleCAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
- ArticleCAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
- ArticleTherapy-related acute myeloid leukemia: Predisposition and clonal hematopoiesis
- ArticleCAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
- ArticleDifferences and analogies between MDS de novo and therapy related.
- ArticleReduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid
- ArticleInfections in Myelodysplastic Syndromes
- Article.
- ArticleSplenectomy and Bacterial Infections.
- ArticleSIMILARITIES OF ELDERLY AND THERAPY-RELATED AML